Status:
COMPLETED
Finding Barriers and Designing Solutions to Promote Women s Cancer Screening in South Africa
Lead Sponsor:
UNC Lineberger Comprehensive Cancer Center
Collaborating Sponsors:
Fogarty International Center of the National Institute of Health
Conditions:
Cervical Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The primary aim of the study explore drivers of cervical cancer screening and barriers contributing to low screening coverage among women in South Africa. Secondary aims are determining preferences fo...
Detailed Description
Cervical cancer is a leading cause of cancer death among South African women. Despite a comprehensive national cancer control policy, cervical screening coverage is low and attrition during on-ward re...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Focus Groups with HIV-positive Women
- HIV-positive
- Women 18 years and older
- Participants should be willing and able to provide written informed consent
- Focus Groups with HIV-negative Women
- HIV-negative
- Women 18 years and older
- Participants should be willing and able to provide written informed consent
- Focus Groups with Men
- Male partners who are 18 years and older
- Participants should be willing and able to provide written informed consent
- In-depth Interviews with Key Stakeholders
- Healthcare providers working within the public health system and other key stakeholders
- Individuals 18 years and older
- Participants should be willing and able to provide written informed consent
- Exclusion Criteria:
- Focus Groups with HIV-positive Women
- Women younger than 18 years
- Unwilling or unable to provide written informed consent
- Focus Groups with HIV-negative Women
- Women younger than 18 years
- Unwilling or unable to provide written informed consent
- Focus Groups with Men
- Male partners younger than 18 years
- Participants unwilling or unable to provide written informed consent
- In-depth Interviews with Key Stakeholders
- Providers who do not work in the public health system
- Individuals younger than 18 years
- Participants unwilling or unable to provide written informed consent
Exclusion
Key Trial Info
Start Date :
July 16 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 20 2023
Estimated Enrollment :
348 Patients enrolled
Trial Details
Trial ID
NCT05414097
Start Date
July 16 2022
End Date
October 20 2023
Last Update
April 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical HIV Research Unit Temba Lethu Wing Helen Joseph Hospital
Westdene, Johannesburg, South Africa, 2092